Asked @JohnLFlavin about the gap @portalinno was looking to fill in Chicago biotech
He said we’ve historically been a net exporter of talent + intellectual property to places like Boston and the Bay
It's good for patients, but it's not necessarily replenishing our ecosystem locally
Portal was designed to be a local market answer / to retain the very people recruited into our universities
Chicago barely had a biotech ecosystem when @JohnLFlavin started Medichem in the 90s
Today, @portalinno is helping build one from the lab bench up
We sat down to talk about how Chicago’s biotech scene has changed, what’s still missing, and what it will take for the city to keep its best scientists and companies here
📺 https://t.co/MeajcDCbBi
Chapters
0:00 Intro
1:09 What changed in Chicago biotech since the 90s
3:30 Why Chicago's universities started working together
6:09 Chicago's edge: AI-enabled biotech
7:35 The gap Portal was built to fill
12:50 Expanding to Houston, Atlanta, Providence & New Jersey
14:13 Replicating wins in a distributed biotech world
16:00 How the Velocity Fund works
18:20 Should Chicago biotech startups seek out coastal capital?
19:56 Grant cuts & non-dilutive funding ($10M to $300M exit)
22:40 Compute access for biotech founders
24:50 What the city should do for founders
26:40 Telling Chicago's biotech story
Portal Innovations, @RecursionPharma, and @AltitudeLab are strengthening Utah's life sciences ecosystem!
Altitude will join Portal at Woodbine Labs as its anchor member, bringing its accelerator and startup community to SLC in February 2027.
Read more: https://t.co/UuIX3JLgdN
Alexis Borisy joins John Flavin to discuss building biotech companies and rethinking early-stage innovation at @Curie_Bio: https://t.co/A3plUIgTig
Thanks to @ChiBiomed for making it possible! Catch Alexis at their Midwest BioBuilders Summit on Nov. 12: https://t.co/7awyWOXQH6
I shared my perspective on biotech and pharma with Melissa and team. Strong year for IPOs and M&A through Q3, recent concerns on rate increases notwithstanding. Also touched on the China biotech boom and what the U.S. needs to do to stay competitive especially in early stage R&D.
.@portalinno's @JohnLFlavin on what's ahead for the biopharma trade: "We see a portfolio of companies that are just brimming with opportunities."
https://t.co/NOgPDsaJEq
New episode of Lab Rats to Unicorns!
We chat with @ImmunArtes co-founders Dr. Vilasack Thammavongsa and Dr. Dominique Missiakas about immune evasion, S. aureus, and the journey from academic discovery to biotech company.
Listen to the full episode: https://t.co/trD87860P8
Another successful Portal Pours + Discovery Days at the New Jersey Innovation Hub! Thanks to everyone who joined us for networking, tours, and a conversation on today’s funding landscape, and to our panelists and New Brunswick Development Corporation for their support.
Thank you to everyone who joined us at Ocean State Labs for Life Sciences Day during Rhode Island Startup Week! Leaders from across Rhode Island's life sciences ecosystem came together for conversations on research, entrepreneurship, funding, and more.
#rhodeisland#LifeSciences
The Portal logo is officially up at Woodbine Labs, and we might be biased…but it looks pretty good up there. The buildout is moving quickly, too. A lot more to come from Salt Lake City. Stay tuned!
#slc#utah#biotech#buildout
@jmaxlevin joins @JohnLFlavin to talk biotech’s biggest bets, from Bristol’s “String of Pearls” and immuno-oncology to Ovid, risk, failure, and the future of U.S. biotech.
Listen now: https://t.co/XTyvGfwqVg
Last week we hosted the Joint Meeting of the Strategic Innovation Centers Advisory Council and Innovation Evergreen Fund Advisory Board at NJIH in New Brunswick!
Portal CEO John Flavin joined the panel alongside leaders helping shape New Jersey's innovation ecosystem.
Too many tools. Too many logins. Too many places to manage your Portal experience.
So we built Orbit.
One platform for bookings, billing, events, resources, community, and more.
Orbit is officially live. Thanks to our members whose feedback helped shape it!
Big moment for Chicago-based portfolio company @ClostraBio! CEO Ritu Shah and CSO Brian Meehan joined fellow @Chi_Innovation award winners to ring the @Nasdaq opening bell in NYC.
Congrats to the team on this milestone: https://t.co/QUVjDOj761
iBIO’s LabShare Places Illumina MiSeq Sequencing System at Portal Innovations to Support Chicago’s Life Sciences Startup Community
https://t.co/xdvMsGw8pQ?
What if we could treat disease by fixing its genetic cause? On the latest Lab Rats to Unicorns, Dr. @kiranmusunuru talks CRISPR, building Verve Therapeutics, and the remarkable story of KJ Muldoon’s personalized gene-editing treatment.
Listen now: https://t.co/VztQ9uFyEP
Founders Compass is here!
Up to eight early-stage life sciences companies will receive 12 months of lab and office space at Ocean State Labs, plus access to Portal's network and resources.
Applications close September 24. Learn more: https://t.co/tBTss6a2lZ
What will it take to make quantum technology useful at scale? On the latest Lab Rats to Unicorns, memQ co-founders Manish Singh and Sean Sullivan discuss quantum networking, building frontier tech, and Chicago’s growing quantum ecosystem.
Listen here: https://t.co/ehK1FW11bM
A packed house joined us Friday for our annual Air & Water Show event at Portal. Even with the fog delay, a paper airplane competition kept things flying until the Blue Angels arrived. Thanks to our sponsors, @EnzoLifeSci and @VeloxityL!
A look behind the scenes from our time in Salt Lake City recording last week’s episode of Lab Rats to Unicorns with Andy Robertson, executive director of @BioHiveUtah!
Listen here if you haven't yet: https://t.co/6c11pHxlNa
Portal is now on TikTok! Follow us for videos of our labs, event recaps, interviews...and maybe some terrible dances🕺
Follow here: https://t.co/ioGiyv4CTr